APA
Sharp A. M., Lertphinyowong S., Yee S. S., Paredes D., Gelfond J., Johnson-Pais T. L., Leach R. J., Liss M., Risinger A. L., Sullivan A. C., Thompson I. M. & Morilak D. A. (20200128). Vortioxetine reverses medial prefrontal cortex-mediated cognitive deficits in male rats induced by castration as a model of androgen deprivation therapy for prostate cancer. : Psychopharmacology.
Chicago
Sharp Alexandra M, Lertphinyowong Suphada, Yee Samantha S, Paredes Denisse, Gelfond Jonathan, Johnson-Pais Teresa L, Leach Robin J, Liss Michael, Risinger April L, Sullivan Anna C, Thompson Ian M and Morilak David A. 20200128. Vortioxetine reverses medial prefrontal cortex-mediated cognitive deficits in male rats induced by castration as a model of androgen deprivation therapy for prostate cancer. : Psychopharmacology.
Harvard
Sharp A. M., Lertphinyowong S., Yee S. S., Paredes D., Gelfond J., Johnson-Pais T. L., Leach R. J., Liss M., Risinger A. L., Sullivan A. C., Thompson I. M. and Morilak D. A. (20200128). Vortioxetine reverses medial prefrontal cortex-mediated cognitive deficits in male rats induced by castration as a model of androgen deprivation therapy for prostate cancer. : Psychopharmacology.
MLA
Sharp Alexandra M, Lertphinyowong Suphada, Yee Samantha S, Paredes Denisse, Gelfond Jonathan, Johnson-Pais Teresa L, Leach Robin J, Liss Michael, Risinger April L, Sullivan Anna C, Thompson Ian M and Morilak David A. Vortioxetine reverses medial prefrontal cortex-mediated cognitive deficits in male rats induced by castration as a model of androgen deprivation therapy for prostate cancer. : Psychopharmacology. 20200128.